GSA Capital Partners’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$806K Buy
+17,441
New +$703K 0.05% 644
2025
Q4
– Sell
-62,671
Closed -$1.12M – 1672
2025
Q3
$1.12M Sell
62,671
-134,266
-68% -$1.95M 0.09% 332
2025
Q2
$2.14M Buy
196,937
+98,718
+101% +$1.29M 0.15% 116
2025
Q1
$1.82M Buy
98,219
+84,186
+600% +$1.52M 0.16% 91
2024
Q4
$231K Buy
+14,033
New +$199K 0.02% 1342
2024
Q1
– Sell
-62,583
Closed -$427K – 1599
2023
Q4
$427K Buy
+62,583
New +$348K 0.04% 898
2022
Q2
– Sell
-17,398
Closed -$138K – 1397
2022
Q1
$138K Buy
+17,398
New +$150K 0.02% 1245
2021
Q3
– Sell
-14,782
Closed -$319K – 1410
2021
Q2
$319K Buy
+14,782
New +$299K 0.04% 909

Other funds holding AXGN

GSA Capital Partners's AXGN Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Axogen (AXGN) in Q2 2026: 17,441 shares worth $806K. The stake represents 0.05% of the portfolio and ranks #644 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in AXGN as recently as Q3 2025.

GSA Capital Partners first reported a position in AXGN in Q2 2021 and has held it in 8 quarters since. The position peaked at $2.14M in Q2 2025. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • GSA Capital Partners held 17,441 shares of Axogen worth $806K as of Q2 2026.
  • Axogen was a new GSA Capital Partners position in Q2 2026.
  • Axogen made up 0.05% of GSA Capital Partners's portfolio in Q2 2026, its #644 holding.
  • GSA Capital Partners first reported a position in Axogen in Q2 2021 and has held it in 8 quarters since.
  • GSA Capital Partners's Axogen position peaked at $2.14M in Q2 2025.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.